Brokerages Set Avantor, Inc. (NYSE:AVTR) PT at $27.57

Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have been given a consensus rating of "Moderate Buy" by the fifteen ratings firms that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $27.57.

A number of analysts recently issued reports on AVTR shares. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Monday, October 28th. UBS Group lowered their price target on shares of Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a report on Tuesday, October 8th. Robert W. Baird dropped their price objective on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a report on Monday, October 28th. Royal Bank of Canada reissued an "outperform" rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Finally, Barclays cut their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Friday, October 25th.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of the company's stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company's stock, valued at approximately $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.50% of the company's stock.

Institutional Trading of Avantor

A number of large investors have recently made changes to their positions in AVTR. State Street Corp raised its stake in shares of Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company's stock valued at $578,666,000 after acquiring an additional 8,206,695 shares during the period. 1832 Asset Management L.P. raised its holdings in Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company's stock valued at $180,839,000 after buying an additional 8,038,451 shares during the period. The Manufacturers Life Insurance Company grew its position in shares of Avantor by 653.0% during the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock worth $159,740,000 after buying an additional 5,354,678 shares in the last quarter. FMR LLC boosted its holdings in shares of Avantor by 557.2% during the third quarter. FMR LLC now owns 4,675,283 shares of the company's stock valued at $120,950,000 after acquiring an additional 3,963,912 shares during the period. Finally, Sound Shore Management Inc. CT bought a new stake in Avantor in the second quarter worth about $76,412,000. 95.08% of the stock is currently owned by institutional investors.

Avantor Trading Up 0.1 %

NYSE AVTR traded up $0.02 during trading hours on Friday, hitting $21.06. 3,337,532 shares of the company's stock were exchanged, compared to its average volume of 6,860,813. The business's 50 day moving average is $23.28 and its 200-day moving average is $23.71. Avantor has a 12-month low of $19.59 and a 12-month high of $28.00. The firm has a market capitalization of $14.33 billion, a P/E ratio of 45.78, a price-to-earnings-growth ratio of 2.55 and a beta of 1.35. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.